support@activebiopharma.com
中文版
Menu
Home
Products
Inhibitors
AKT Inhibitors
ALK Inhibitor
ATM Inhibitor
Aurora Kinase Inhibitors
Bcl-2 Protein Family Inhibitors
B-Raf inhibitors
CDK inhibitors
c-Met Inhibitors
EGFR inhibitor
HDAC Inhibitors
Hedgehog inhibitor
HIV Inhibitor
JAK inhibitor
MEK inhibitor
mTOR Inhibitor
PARP inhibitor
PI3K Inhibitor
PKC Inhibitor
PLK1 Inhibitor
Other inhibitors
Activator
Agonist
antagonist
API
Aurora
Metabolic Disease
VEGFR-PDGFR
Other Intermediate
Others
MOF Chemicals
About Us
Custom Synthesis
Order & Payment
Contact Us
Name Index M
Home
/
Name Index M
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
CAS
Chemical Name
Cat.No.
MolFormula
657-24-9
MetforMin
ABP009582
C4H11N5
1665-48-1
Metaxalone
ABP009581
C12H15NO3
158013-42-4
meta-iodoHoechst 33258
ABP009580
72-33-3
Mestranol
ABP009579
C21H26O2
74641-30-8
Meso-1,2-Bis(4-chlorophenyl)ethylenediamine
ABP009578
C14H14Cl2N2
19767-45-4
Mesna
ABP009577
C2H5O3S2.Na
137624-14-7
Mesatlantin C
ABP009576
119478-56-7
Meropenem (trihydrate)
ABP009575
C17H25N3O5S
96036-03-2
Meropenem
ABP009574
C17H25N3O5S
198821-22-6
Merimepodib
ABP009573
131-72-6
Meptyldinocap
ABP009572
C18H24N2O6
59263-76-2
Meptazinol (hydrochloride)
ABP009571
C15H23NO.ClH
54340-58-8
MeptaMizol
ABP009570
C15H23NO
1247-42-3
Meprednisone
ABP009569
C22H28O5
1722-62-9
Mepivacaine (hydrochloride)
ABP009568
C15H22N2O.ClH
58-27-5
Menadione
ABP009567
C11D8O2
41100-52-1
Memantine (hydrochloride)
ABP009566
C12H21N.ClH
71125-38-7
Meloxicam
ABP009564
C14H13N3O4S2
73-31-4
Melatonin
ABP009563
C13H16N2O2
334951-92-7
MEK inhibitor
ABP009561
C26H26N4O2
97207-47-1
Meisoindigo
ABP009560
C17H12N2O2
6284-40-8
Meglumine
ABP009559
C7H17NO5
51773-92-3
Mefloquine (hydrochloride)
ABP009557
C17H16F6N2O.ClH
« Pre
42
43
44
45
46
47
48
49
50
51
Next »
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Copyright © 2015-2025 Active Biopharma Corp. All rights reserved. Support by
Moldb
.
浙ICP备11021315号-3
浙公网安备 33010802003999号
Scroll